Jennifer Lynne Fox - Feb 23, 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Ext Aff, GC, Corp Sec
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Feb 23, 2023
Transactions value $
-$6,840
Form type
4
Date filed
2/27/2023, 07:22 PM
Previous filing
Dec 13, 2022
Next filing
Mar 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$3.3K -231 -0.26% $14.30 88.2K Feb 23, 2023 Direct F1
transaction EBS Common Stock Tax liability -$3.54K -258 -0.29% $13.71 87.9K Feb 24, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.